Gå direkte til innhold

Global vaksinasjonsforskning 2009 - generell og norsk-indisk utlysning

Minst 60 millioner kroner er tilgjengelig for forskerprosjekt, prosjekt for yngre forskere og brukerstyrte innovasjonsprosjekt (2010-2012) for å utvikle og gjøre tilgjengelig vaksiner i lav- og mellominntektsland. Norske institusjoner kan søke, og det er ønskelig med internasjonalt samarbeid.

Forskerprosjekt Velg
Brukerstyrt innovasjonsprosjekt Velg
04.06.2009 13:00 CEST


Utlysningsteksten foreligger kun på engelsk



Antatt tilgjengelige midler:

A total of up to 60 mill. NOK or approximately 9 mill. USD is available from the Research Council of Norway for this call. Indo-Norwegian projects are part of this call, and can apply for matched funding from Department of Biotechnology, India as specified in the guidelines.

Føringer og viktige forhold for alle søknadstyper i utlysningen:

This call is for project proposals of the following types:
1) Researcher Projects
2) User-driven Innovation Projects
3) Young Scientist Grant ("Other Personal Grant")
Below are guidelines that apply to all proposals, and additional guidelines for Indo-Norwegian proposals, that are submitted under this call.

The proposal must be within the field of global vaccination research, which is here defined as
research aiming at providing existing and improved vaccines for marginalized populations, especially children, in low- and middle-income countries. This includes epidemiological studies, the development and evaluation of new or improved vaccines, implementation of vaccination strategies, and studies to measure the costs and outcomes of such strategies. Further, the proposal must be within the overall aims of the GLOBVAC programme as stated above.


This call will encourage, but is not restricted to, proposals focusing on:

  • diseases and health problems that account for a large proportion of the global disease burden
  • diseases and health problems that are neglected
  • thematic areas where Norway is strongly involved in health programmes and research
  • thematic areas where Norway has the capacity and competence to be in the international forefront


The following types of studies are included in this call:

  • development of diagnostic tools, and identification of the need for vaccination programmes based on epidemiological studies
  • development of new candidate vaccines and identification of optimal formulations and immunization regimens for new and existing vaccines
  • development of methods to assess vaccine-induced protection (immune correlates), toxicity and side-effects
  • determination of the impact of vaccination, including protective efficacy and effectiveness for relevant outcome parameters and the development of national surveillance systems
  • increasing the availability and ensuring equitable coverage of existing vaccines
  • stimulation of technology transfer to low- and middle-income countries, including improved strategies for cost-effective production of vaccines and the development of trial sites

Projects should normally run for a period of 3 years, and must be completed by the end of 2012.

Eligible applicants are public and private Norwegian institutions. Allocation of funds must contribute to developing high quality projects with participation of Norwegian research groups and/or institutions. Eligible project managers are Norwegian or other citizens residing at the time of application in Norway or abroad.

International collaboration is encouraged, including partnerships with low- and middle-income countries. Funding from the programme can be spent overseas. International research groups or institutions can access funding from the programme as partners on proposals from Norwegian public or private institutions. Proposals must define tasks and funding for each of the international collaborators of the project.

Capacity building: It should be demonstrated that the project can lead to research capacity building in Norway and, when applicable, amongst collaborative partners in low- and middle-income countries.

Budget: Projects should have budgets with 1-5 million NOK annually funded from this programme. Projects are encouraged to secure additional funding from other sources (eg. EU-funding, own funding). Further, projects with own/additional funding and projects that can demonstrate sustainable commitments from own institution or other sources during and/or beyond the project period are encouraged. It is recommended that partners/ staff in low- and middle-income countries are paid according to local salary levels.

The scope of the project should be realistic within the time frame and budget limitations of the project.

Participation of master and PhD students and post doctoral fellows should be integral components of a larger project proposal. Proposals consisting of an individual fellowship only will not be given priority. (See special guidelines for Young Scientist Grants).

Scientific results should be made available to all partners in the project. It is strongly encouraged to publish in peer-review journals that are accessible to scientists in low- and middle-income countries if possible. The Research Council of Norway (RCN) has recently adopted a set of principles for open access to scientific publications, establishing that scientific journal articles based on R&D projects funded by the RCN must be stored in open digital archives, making them available to all interested parties, as long as this type of archiving does not infringe on the rights of authors or publishers. The guidelines are described in more detail in the document "NFRs prinsipper for open access", and a framework for implementing these guidelines is under development.


  • Applications (application form, project description and appendices) must be submitted electronically using "e-søknad"
  • The application and project description (a maximum of 10 pages, font Times New Roman 12 point, footnotes and references included) must be well structured and clearly written in English
  • Activities should be clearly described according to a timeline, and could be organized into work packages when appropriate
  • Milestones should be identified that can be used to easily follow the progress of the project.
  • Budget information should be detailed and clearly presented, and should, when necessary, be specified in the project description or in a separate attachment
  • Proposals should include considerations on ethics, capacity building and sustainability
  • All international cooperation must be documented
  • Appendices should be limited to relevant information only. CVs should be kept short, with only the most recent information


  • Evaluation will be based on scientific merits, relevance for the programme goals and the guidelines of this call, hereunder elements such as strength of the institution, strategic use of the funding and the probability for success
  • International experts will be used in evaluation of  the scientific quality

The GLOBVAC programme board will evaluate and ultimately decide, and at its discretion, which projects will receive funding and the amount of the allocations.



The Department of Biotechnology (DBT), Ministry of Science & Technology, Govt. of India and The Research Council of Norway (RCN) have established collaborative efforts between India and Norway in the field of human vaccination research, including joint calls for proposals and joint research projects between Indian and Norwegian scientists.

This collaboration is based upon early key meetings between Indian and Norwegian stakeholders in Bergen and New Delhi during 2006, that yielded a Roadmap on Indo-Norwegian collaboration in vaccination research. The roadmap set out guiding principles for this collaboration, but the joint calls for proposals are not limited to those institutions or companies mentioned in this document. The collaboration on human vaccination research is now part of the Programme for Global Health Research (GLOBVAC) at the RCN, as described in the GLOBVAC programme plan (link), and DBT.

Accordingly, proposals from investigators-driven research initiatives with interactive collaborative efforts across institutions and disciplines in areas of human vaccination research are invited. Both RCN and DBT will provide matched financial support to promote the development of the vaccination sector in India and Norway. This will also create a foundation on which the two countries may cooperate on marketing new discoveries and related product/process development. Collaborative research components may comprise both basic and applied research. This call will include researcher projects but also business and industry involvement through user-driven innovation projects. This initiative would ensure the implementation of projects that encompass collaboration between different institutions and disciplines, with a view to promote optimal knowledge, skill development and appropriate platform for technology promotion and dissemination to the end users benefiting both countries.

Thematic guidelines
The thematic guidelines given above also apply to the Indo-Norwegian proposals, with the following modifications:

This call will encourage, but is not restricted to, proposals focusing on:

  • thematic areas where Norway and India are strongly involved in health programmes and research
  • thematic areas where Norway and India has the capacity and competence to be in the international forefront
  • thematic areas where synergy effects between Norway and India can be expected
    Examples of relevant thematic areas are HIV/AIDS, respiratory and enteric infections, tuberculosis, influenza, meningococcal disease and human papilloma virus.

How to apply
The Norwegian and Indian collaborating investigators are required to prepare a joint application for the main research project. Applications should be submitted to both the RCN and the DBT. The applications to RCN should be submitted via the eSøknad electronic application system. The applications to the DBT should be submitted electronically (6 copies also by post) on Indian application form, to Mr. S. Sinha:  ssinha.dbt@gmail.com (DBT website: www.dbtindia.nic.in).

All relevant points of the application forms must be completed. The application to the RCN and to DBT should contain an identical project description, describing both the Indian and the Norwegian activities in the project, an overview of proposed annual and overall expenses associated with Norwegian and Indian project activities as well as a funding plan specifying Norwegian and Indian funding sources respectively. All applications submitted to the RCN will be subject to the Research Council's general rules regarding the application types in question and the DBT will follow its own norms and procedures.

Time line and budget
Projects should run over a period of 3 years, and must be completed by the end of 2012. The Indian side will initially grant funding for a period of 3 years, with the possibility for a one year extension. Earliest possible start of projects is January 1st 2010. The Research Council of Norway will fund the activities proposed by the Norwegian investigator(s), while costs proposed by the Indian investigator(s) will be provided by the Department of Biotechnology (DBT), India. Proposals should have annual budgets of 1-5 mill. NOK (0.15 - 0.75 mill. USD) from the RCN, and matched funding from the DBT.

Proposal submission
For the Indian side, proposals should be sent to S. Sinha, Adviser, Department of Biotechnology, Block-II, CGO Complex, Lodhi Road, New Delhi 110003 by e-mail (ssinha.dbt@nic.in ) and also by post (6 copies). For further queries/clarifications, please contact at Tel. 011-24363760. Website: www.dbtindia.nic.in.

For the Norwegian side, proposals should be submitted using the electronic application form "e-Søknad" (choose application type at the top of this page, confirm the acceptance of conditions, and click "Create new application" at the top of this page). The deadline for submission is June 4th 2009, 13:00 hrs, Norwegian time

Review process
All grant applications will be assessed for scientific merit by international experts selected jointly by the RCN and DBT. The RCN's forms and guidelines for international review of grant proposals will be utilised in the assessment process. Subsequently, the applications and the review comments will be presented to the decision-making bodies in Norway (the Programme Board for Global Health and Vaccination Research, GLOBVAC) and India (DBT). The decision-making bodies will evaluate the scientific merit, utility and relevance of the proposals, and are responsible for allocating funds to their own countrys part of the application.

Award criteria
The main criteria for award decision will primarily include the following:
1. Scientific merit of the project
2. Expertise with the Principal Investigator(s) and networking/collaborating team
3. Competence to enter into collaborative arrangements
4. Availability of core infrastructure and support facilities to carry out the proposed project at host institute(s)
5. Utility and relevance (for the guidelines of this call)
6. Strategic use of the funding and the probability for success

Specific criteria are mentioned in the guidelines for each application type.

The RCN will enter into a contract with the Norwegian applicant for the Norwegian share of the project. Likewise, DBT will enter into a contract with the Indian applicant for the Indian share of the project.

Agreement on rights to and use of findings
Before entering into a contract, the concerned parties shall sign a consortium agreement specifying the rights to and use of findings (IPR) in consultation with DBT and RCN.

Time line
Receipt of proposals: June 4th 2009. 13:00 hrs (Norwegian time)
Award decision and notification: November/December, 2009

Andre nettsider